Teck and CPKC announce long-term rail agreement PR Newswire CALGARY, AB and VANCOUVER, BC, May 4, 2023 CALGARY, AB and VANCOUVER, BC, May 4, 2023 /PRNewswire/ - Canadian Pacific Kansas City...
MINNEAPOLIS, Feb. 2 /PRNewswire-FirstCall/ -- Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.26 per share for the quarter ended...
MINNEAPOLIS, Oct. 29 /PRNewswire-FirstCall/ -- Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.26 per share for the quarter ended...
MINNEAPOLIS, Oct. 28 /PRNewswire-FirstCall/ -- Techne Corporation's (NASDAQ:TECH) consolidated net earnings for the quarter ended September 30, 2009 decreased 6.4% to $26.8 million or $.72 per...
MINNEAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended June...
ARLINGTON, Va., June 18 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, Exploring the Epigenetics Market: Opportunities for Product Placement and...
MINNEAPOLIS, June 10 /PRNewswire-FirstCall/ -- Charles A. Dinarello, M.D., a Professor of Medicine at the University of Colorado School of Medicine in Denver and a member of the Techne...
MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (NASDAQ: TECH) today announced that Mr. John L. Higgins has accepted a position on Techne's Board of Directors and will also...
ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and...
ARLINGTON, Va., April 7 /PRNewswire/ -- BioInformatics, LLC announces the pending release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales